Evidence map›Paper›PMID 39413158›Full record

ArticleNucleic acids research2024

Core enhancers of the 3'RR optimize IgH nuclear position and loop conformation for successful oriented class switch recombination.

Charlotte Bruzeau, Ophélie Martin, Justine Pollet, Morgane Thomas, Zhaoqing Ba, David Roulois, Eric Pinaud, Sandrine Le Noir

Abstract read
In one paragraph

Article in Nucleic acids research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Charlotte BruzeauUMR CNRS7276, Inserm1262, Université de Limoges: Contrôle de la Réponse Immune B et des Lymphoproliférations, Team 2, B-NATION: B Cell Nuclear Architecture, Immunoglobulin Genes and Oncogenes, 2, rue du Dr. Marcland, 87025 Limoges, France.
Ophélie MartinUMR CNRS7276, Inserm1262, Université de Limoges: Contrôle de la Réponse Immune B et des Lymphoproliférations, Team 2, B-NATION: B Cell Nuclear Architecture, Immunoglobulin Genes and Oncogenes, 2, rue du Dr. Marcland, 87025 Limoges, France.
Justine PolletUMR CNRS7276, Inserm1262, Université de Limoges: Contrôle de la Réponse Immune B et des Lymphoproliférations, Team 2, B-NATION: B Cell Nuclear Architecture, Immunoglobulin Genes and Oncogenes, 2, rue du Dr. Marcland, 87025 Limoges, France.
Morgane ThomasUMR CNRS7276, Inserm1262, Université de Limoges: Contrôle de la Réponse Immune B et des Lymphoproliférations, Team 2, B-NATION: B Cell Nuclear Architecture, Immunoglobulin Genes and Oncogenes, 2, rue du Dr. Marcland, 87025 Limoges, France.
Zhaoqing BaNational Institute of Biological Sciences, 37WH+XG9, Changping District, Beijing 102206, China.
David RouloisHoneycomb team, Equipe Labellisée par la Ligue Nationale contre le Cancer, UMR 1236, Université de Rennes, INSERM, Établissement Français du Sang Bretagne, 2 avenue du professeur Léon Bernard, F-35043, Rennes, France.
Eric PinaudUMR CNRS7276, Inserm1262, Université de Limoges: Contrôle de la Réponse Immune B et des Lymphoproliférations, Team 2, B-NATION: B Cell Nuclear Architecture, Immunoglobulin Genes and Oncogenes, 2, rue du Dr. Marcland, 87025 Limoges, France.
Sandrine Le NoirUMR CNRS7276, Inserm1262, Université de Limoges: Contrôle de la Réponse Immune B et des Lymphoproliférations, Team 2, B-NATION: B Cell Nuclear Architecture, Immunoglobulin Genes and Oncogenes, 2, rue du Dr. Marcland, 87025 Limoges, France.ORCID 0000-0002-2297-4186

Funding

Agence Nationale de la Recherche ANR-21-CE15-0001-0CARNOT CALYM InstituteFondation ARC pour la Recherche sur le CancerFonds Européen de Développement RégionalLa Ligue Contre le Cancer comités 87Ministère de l'Enseignement Supérieur, de la Recherche et de l'Innovation
6 · The paper itself

Abstract

In B lymphocytes, class switch recombination (CSR) is an essential process that adapts immunoglobulin (Ig) subtypes to antigen response. Taking place within the Ig heavy chain (IgH) locus, CSR needs controlled transcription of targeted regions governed by the IgH 3' regulatory region (3'RR). This super-enhancer is composed of four core enhancers surrounded by inverted repeated sequences, forming a quasi-palindrome. In addition to transcription, nuclear organization appears to be an important level in CSR regulation. While it is now established that chromatin loop extrusion takes place within IgH locus to facilitate CSR by bringing the donor and acceptor switch regions closer together, the underlying mechanism that triggers CSR loop formation remains partially understood. Here, by combining DNA 3D fluorescence in situhybridization with various high-throughput approaches, we deciphered critical functions for the 3'RR core enhancer element in nuclear addressing, accessibility and chromatin looping of the IgH locus. We conclude that the 3'RR core enhancers are necessary and sufficient to pre-organize the position and conformation of IgH loci in resting B-cell nuclei to enable the deletional recombination events required for productive successful CSR in activated B-cell nuclei.

Indexed as

B-LymphocytesCell NucleusChromatinEnhancer Elements, GeneticImmunoglobulin Class SwitchingImmunoglobulin Heavy ChainsAnimalsMiceNucleic Acid ConformationRecombination, GeneticChromatinImmunoglobulin Heavy Chains

Identifiers

PMID39413158
PMCPMC11551739

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.